Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings.
Cathepsin D (CD, EC 3.4.23.5) is a lysosomal protease induced by estrogen in certain estrogen receptor (ER)-positive breast cancer cell lines but produced constitutively by ER-negative cell lines. Our aims in this investigation were to study the distribution of CD in human breast cancers and to relate its concentrations to various biochemical, histological, and clinical characteristics. The concentrations of CD were significantly higher in breast carcinomas than in either normal breast tissues or benign breast tumors. In primary carcinomas, CD concentrations did not correlate with the concentrations of ER or with the estrogen-inducible protease t-PA. However, CD concentrations did correlate weakly but significantly with both UK-PA antigen and UK-PA activity. Also, CD concentrations did not correlate with either tumor stage or axillary node status but did correlate significantly with tumor grade. Patients with cancers containing high concentrations of CD had a significantly shorter overall survival than did patients with low concentrations of the enzyme.
Duffy
M J
MJ
Department of Nuclear Medicine, St. Vincent's Hospital, Dublin, Ireland.
Brouillet
J P
JP
Reilly
D
D
McDermott
E
E
O'Higgins
N
N
Fennelly
J J
JJ
Maudelonde
T
T
Rochefort
H
H
D001943:Breast Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D002402:Cathepsin D / Q000378:metabolism*; D003600:Cytosol / Q000201:enzymology; D006801:Humans; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D011960:Receptors, Estrogen; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator; D002402:Cathepsin D